<DOC>
	<DOCNO>NCT00093925</DOCNO>
	<brief_summary>The purpose study establish safety clevidipine treatment postoperative hypertension . Approximately 250-500 patient postoperative hypertension undergo coronary artery bypass grafting ( CABG ) , off-pump coronary artery bypass ( OPCAB ) minimally invasive direct coronary artery bypass ( MIDCAB ) surgery and/or valve replacement/repair procedure anticipate randomly assign one two treatment group : clevidipine nicardipine .</brief_summary>
	<brief_title>Clevidipine Postoperative Treatment Hypertension ( ECLIPSE-NIC )</brief_title>
	<detailed_description>The primary objective establish safety clevidipine treatment postoperative hypertension , assess compare incidence death , stroke , MI renal dysfunction clevidipine nicardipine treatment group initiation study drug infusion postoperative Day 30 . Secondary objective evaluate efficacy study drug , assess blood pressure ( BP ) lower effect , additional safety variable .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nicardipine</mesh_term>
	<mesh_term>Clevidipine</mesh_term>
	<criteria>Prerandomization Provide write informed consent initiation study related procedure . Be least 18 year age Be schedule Coronary Artery Bypass Grafting ( CABG ) , Off Pump Coronary Artery Bypass ( OPCAB ) , Minimally Invasive Direct Coronary Artery Bypass ( MIDCAB ) surgery , and/or valve replacement/repair surgery Prerandomization Women childbearing potential ( unless negative pregnancy test ) Recent cerebrovascular accident ( within 3 month randomization ) Known intolerance calcium channel blocker Known suspect hypersensitivity nicardipine Allergy soybean oil egg lecithin ( component lipid vehicle ) Preexisting permanent ventricular pace Any disease condition , , judgment investigator would place patient undue risk enrol trial Participation another therapeutic drug therapeutic device trial within 30 day start study Postrandomization Expected survive beyond 24 hour postsurgical procedure No surgical complication condition , present anticipate , preclude inclusion study Determined hypertensive postoperatively determine investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Postoperative hypertension</keyword>
</DOC>